AmerisourceBergen

AmerisourceBergen, which rebranded as Cencora in August 2023, is a global pharmaceutical solutions organisation active in pharmaceutical distribution, manufacturer support, provider services and animal health. The company employs more than 44,000 people across over 1,300 locations worldwide and reports annual revenue in excess of $200 billion, placing it at number 11 in the Fortune 500.

Its core business is wholesale and specialty distribution, ensuring that medications reach their destinations efficiently, reliably and securely; the company serves 100% of U.S. hospitals. Around this sit manufacturer support services that partner with pharmaceutical innovators across the value chain to optimise market access to therapies, and provider services supporting specialty pharmacies, hemophilia centres and home healthcare companies. Animal health solutions extend the same model to animal health providers worldwide.

Relevant technical domains include pharmaceutical distribution, specialty distribution, supply chain and logistics, market access optimisation, and pharmaceutical access and care solutions. The company describes itself as mission-driven, with an emphasis on improving access to healthcare for people and animals, and has unified its companies and services under a single name to reflect a global role and a one-team culture.